Patents by Inventor Charles E. Ducker

Charles E. Ducker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of NF-?B
    Patent number: 8629164
    Abstract: The invention relates to compounds of formulae (1) and (2): and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: January 14, 2014
    Assignee: Profectus Biosciences, Inc.
    Inventors: Jie Zhang, Drago Robert Sliskovic, Charles E. Ducker
  • Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
    Publication number: 20120088827
    Abstract: The invention relates to compounds of formula (I), formula (II), formula (III) and formula (IV), and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
    Type: Application
    Filed: June 16, 2010
    Publication date: April 12, 2012
    Applicant: Profectus Biosciences, Inc.
    Inventors: Jie Zhang, Drago Robert Sliskovic, Charles E. Ducker
  • Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
    Publication number: 20120046357
    Abstract: The invention relates to compounds of formula (1) and formula (2), and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries, wherein R1 is defined herein.
    Type: Application
    Filed: April 29, 2010
    Publication date: February 23, 2012
    Applicant: Profectus Biosciences, Inc.
    Inventors: Jie Zhang, Drago Robert Sliskovic, Charles E. Ducker
  • Inhibitors of NF-KB
    Publication number: 20120015952
    Abstract: The invention relates to compounds of formulae (1) and (2): and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
    Type: Application
    Filed: March 25, 2010
    Publication date: January 19, 2012
    Applicant: Profectus Biosciences, Inc.
    Inventors: Jie Zhang, Drago Robert Sliskovic, Charles E. Ducker